MeiraGTx Holdings (MGTX) Cash from Operations (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 482.20% |
| Sep 30, 2025 | 72.28% |
| Jun 30, 2025 | -19.40% |
| Mar 31, 2025 | -58.22% |
| Dec 31, 2024 | 6.98% |
| Sep 30, 2024 | -28.61% |
| Jun 30, 2024 | 47.05% |
| Mar 31, 2024 | -152.57% |
| Dec 31, 2023 | 40.42% |
| Sep 30, 2023 | 15.85% |
| Jun 30, 2023 | 22.41% |
| Mar 31, 2023 | -129.86% |
| Dec 31, 2022 | 21.51% |
| Sep 30, 2022 | 25.46% |
| Jun 30, 2022 | -235.10% |
| Mar 31, 2022 | -144.07% |
| Dec 31, 2021 | 209.57% |
| Sep 30, 2021 | 19.18% |
| Jun 30, 2021 | -334.00% |
| Mar 31, 2021 | 130.74% |
| Dec 31, 2020 | -223.40% |
| Sep 30, 2020 | 29.03% |
| Jun 30, 2020 | -4.01% |
| Mar 31, 2020 | 43.64% |
| Dec 31, 2019 | -19.37% |
| Sep 30, 2019 | 15.35% |
| Jun 30, 2019 | -126.46% |
| Mar 31, 2019 | 816.44% |
| Dec 31, 2018 | -4.32% |
| Sep 30, 2018 | 42.23% |
| Jun 30, 2018 | -9.39% |
| Mar 31, 2018 | -368.96% |
| Dec 31, 2017 | 2.77% |